Charlie S Holdings Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Charlie S Holdings Inc (CHUC) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Charlie S Holdings Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 24M vs 210,235M combined for its competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-36.1% annualized vs trailing 12 months), vs accelerating (+7.3%) for its tracked peer group.
- Growth: Charlie S Holdings Inc generated 49.5% revenue growth year over year in Q2 2026, vs 15.6% for its competitors combined.
- Profitability: Its -43.7% net margin compares with 19.0% for the peer group.
- Scale: Charlie S Holdings Inc ranks #14 of 37 companies by market capitalization in the Legal Cannabis industry, holding 0.3% of industry market cap.
- Peer revenue share: Charlie S Holdings Inc accounted for 0.0% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.68M compares with $0.49M for the peer group (1.4x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CHUC Sales vs. its Competitors, Q2 2026
Charlie S Holdings Inc reported revenue growth of 49.45 % year on year in Q2 2026, above its competitors' combined revenue growth of 15.57 %.
With a net margin of -43.71 %, Charlie S Holdings Inc reported lower profitability than its competitors (19.01 %).
Charlie S Holdings Inc generated 0.01 % of the combined sales of its peer group, up from 0.01 % a year earlier.
API endpoints for this dataset
Charlie S Holdings Inc vs. its Competitors, Q2 2026
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Charlie S Holdings Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Charlie S Holdings Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Charlie s Holdings Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (5) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (5) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Charlie S Holdings Inc's competitor groups requires a Commercial License.
For context: the Legal Cannabis industry grew revenue 21.4% year over year, combined, vs 49.5% for Charlie S Holdings Inc. Charlie S Holdings Inc's share of combined industry revenue moved from 0.10% to 0.12%, a gain of 0.02 percentage points.
Charlie S Holdings Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Charlie s Holdings Inc | No | Yes | Yes | Yes |
| Competitors combined (12) | ||||
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 50.00 % (4 of 8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 12.50 % (1 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
CHUC Stock Performance relative to its Competitors
CHUC Stock Performance relative to Similar-Size Competitors
CHUC Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Coca cola Consolidated Inc | 282.9% | Outperformed |
| 2 | Coca Cola Co | 282.9% | Outperformed |
| 3 | Jones Soda Co | 282.9% | Outperformed |
| 4 | Keurig Dr Pepper Inc | 282.9% | Outperformed |
| 5 | Altria Group Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Charlie S Holdings Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Charlie S Holdings Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Charlie s Holdings Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Charlie s Holdings Inc |
28.78 | 23.79 |
 Coca Cola Co |
411,040.51 | 51,054.00 |
 Pepsico Inc |
192,760.67 | 98,241.00 |
 Altria Group Inc |
125,633.98 | 20,817.00 |
 Monster Beverage Corp |
90,208.59 | 9,218.64 |
 Keurig Dr Pepper Inc |
50,172.67 | 20,090.00 |
| SUBTOTAL | 881,809.08 | 211,439.48 |
Sign in to see all competitors of Charlie s Holdings Inc .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Charlie s Holdings Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Charlie S Holdings Inc's Competitors Named by the Company
Competitive relationships identified from Charlie S Holdings Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Altria Group Inc | Company report | 85% |
| Reynolds American Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Charlie S Holdings Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Charlie S Holdings Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Coca Cola Co | North America 40.24 % |
| Pepsico Inc | PepsiCo Beverages North America 30.49 % |
| Altria Group Inc | Smokeable Products 88.58 % |
| Monster Beverage Corp | Monster Energy Drinks segment 92.60 % |
| Keurig Dr Pepper Inc | U.S. Refreshment Beverages 40.02 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Charlie s Holdings Inc .
Charlie S Holdings Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Charlie s Holdings Inc | 29 | 679,629 | -55,914 |
| Coca Cola Co | 411,041 | 774,719 | 223,308 |
| Pepsico Inc | 192,761 | 321,049 | 35,768 |
| Altria Group Inc | 125,634 | 3,528,305 | 1,375,593 |
| Monster Beverage Corp | 90,209 | 1,337,780 | 308,761 |
| Keurig Dr Pepper Inc | 50,173 | 656,536 | 48,856 |
| PEERS TOTAL | 881,780 | 486,522 | 87,964 |
Sign in to see all peers for Charlie s Holdings Inc .
Charlie S Holdings Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Coca Cola Co | Non-US 60.70 % |
| Monster Beverage Corp | U.s.And Canada 55.90 % |
| Celsius Holdings Inc | North America 95.16 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Charlie S Holdings Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 24 companies in Charlie S Holdings Inc's industry classification, broader than the peer set above. Market cap in millions of $.Charlie S Holdings Inc ranks #14 of 24 companies by market capitalization in its industry, holding 0.30 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 2,404, indicating a moderately concentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Definium Therapeutics Inc | 3,682 | 37.89 % |
| 2 | Regencell Bioscience Holdings Limited | 2,606 | 26.82 % |
| 3 | Cronos Group Inc | 1,354 | 13.93 % |
| 4 | Sndl Inc | 355 | 3.65 % |
| 5 | Tilray Brands Inc | 1,234 | 5.2% |
| 6 | Aurora Cannabis Inc | 1,234 | 5.2% |
| 7 | Canopy Growth Corporation | 1,234 | 5.2% |
| 8 | Usana Health Sciences Inc | 1,234 | 5.2% |
| 9 | Niagen Bioscience Inc | 1,234 | 5.2% |
| 10 | Mediwound Ltd | 1,234 | 5.2% |
| 14 | Charlie s Holdings Inc | 29 | 0.30 % |
Market cap and industry share for the rest of Charlie S Holdings Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-06.
Charlie S Holdings Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 9 | Niagen Bioscience Inc | 171 | -69.84 % |
| 10 | Mediwound Ltd | 162 | -25.51 % |
| 11 | Fitlife Brands Inc | 79 | -58.11 % |
| 12 | Upexi Inc | 41 | -81.92 % |
| 13 | Biote Corp | 1,234 | 12.3% |
| 14 | Charlie s Holdings Inc | 29 | -50.02 % |
| 15 | China Foods Holdings Ltd | 1,234 | 12.3% |
| 16 | Mannatech Inc | 1,234 | 12.3% |
| 17 | Pioneer Green Farms Inc | 1,234 | 12.3% |
| 18 | Natural Alternatives International Inc | 1,234 | 12.3% |
| 19 | Cyanotech Corp | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Charlie S Holdings Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-11-06. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Charlie S Holdings Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Legal Cannabis industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (43 companies). See the full Legal Cannabis industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 28.42 % | 37.68 % (avg) | -9.3 pp |
| Operating Margin | -11.23 % | industry median | -10.3 pp |
| EBITDA Margin | -9.05 % | -1.95 % (avg) | -7.1 pp |
| Capital Intensity (Capex / Revenue) | 0.10 % | 5.10 % (avg) | -5.0 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Charlie S Holdings Inc's Valuation vs Competitive Position
Valuation multiples vs the Legal Cannabis industry average (43 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Legal Cannabis industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 19.1x | - |
| EV / EBITDA | - | 8.2x | - |
| P/B | 20.8x | 3.8x | +17.0x |
| Return on Equity | -60.66 % | industry aggregate | -37.45 % |
| Return on Invested Capital | -32.54 % | -5.04 % (avg) | -27.50 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Charlie S Holdings Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | -49.07 % | 500.00 % | -26.60 % | 28.78 % | 22.93 % | -38.50 % | -47.73 % | 143.17 % |
| Operating Margin | -549.06 % | -25.35 % | -40.56 % | 2.63 % | -6.83 % | - | -40.64 % | -10.48 % |
| Return on Invested Capital | - | -2,381.22 % | - | - | -26.81 % | - | - | -60.89 % |
| P/E | - | - | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Charlie S Holdings Inc's Strategic Group Map
Charlie S Holdings Inc is shown in red; its closest peers by combined growth, margin and ROIC are labeled. See Methodology: Strategic Group Map for how this chart is built.
Charlie S Holdings Inc's trailing-12-month revenue growth of 188.3% and operating margin of -11.2% compares with an average of 98.7% growth and -5.6% margin across its 8 closest peers by combined growth, margin and ROIC -- Charlie S Holdings Inc sits above that peer average on growth and below it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Charlie S Holdings Inc's BCG Growth-Share Matrix
See Methodology: BCG Growth-Share Matrix for how relative share and growth are calculated and thresholded.
Charlie S Holdings Inc falls in the Dog quadrant: relative market share of 0.01x vs its largest competitor, in an industry growing revenue 0.8% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution. A caveat worth reading alongside this chart: Definium Therapeutics Inc alone holds 38% of this industry's market cap. In an industry this dominated by one leader, the framework will place nearly every OTHER company in "Dog" or "Question Mark" purely because relative share is measured against that leader, regardless of how strong those other companies actually are on their own fundamentals. Check the Profitability, Valuation and Financial Strength sections above before treating this quadrant label as a verdict.
Charlie S Holdings Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Moderate | Industry HHI of 2,404 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.10 % vs industry average 5.10 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Charlie S Holdings Inc's dedicated Suppliers and Customers pages, not here.
Charlie S Holdings Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Charlie S Holdings Inc falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Charlie S Holdings Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Operating margin 10.3 points below the industry median.
- Return on equity 37.5 points below the industry aggregate.
- Latest-quarter revenue run-rate is decelerating (-36.1% annualized vs trailing 12 months).
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.01x).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
- Industry dominated by Definium Therapeutics Inc , holding 37.89 % of industry market cap.
Methodology: see Methodology: SWOT Analysis.
Charlie S Holdings Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Charlie s Holdings Inc | 0.12 | 1.51 | 0.34 |
| Coca Cola Co | 0.28 | 1.37 | 1.74 |
| Pepsico Inc | 0.30 | 0.91 | 2.38 |
| Altria Group Inc | 0.39 | 0.59 | - |
| Monster Beverage Corp | 1.31 | 3.46 | - |
| Keurig Dr Pepper Inc | 0.48 | 0.93 | 0.80 |
Sign in to see all peers for Charlie s Holdings Inc .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Charlie S Holdings Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Charlie s Holdings Inc | Q2 2026 | +49.4 % | - |
| Coca Cola Co | Q3 2026 | +7.4 % | +8.9 % |
| Pepsico Inc | Q3 2026 | +5.6 % | +16.4 % |
| Altria Group Inc | Q3 2026 | +32.4 % | +6.0 % |
| Monster Beverage Corp | Q2 2026 | +20.2 % | +19.6 % |
| Keurig Dr Pepper Inc | Q2 2026 | +75.6 % | -61.6 % |
| PEERS TOTAL | +15.1 % | +5.7 % |
Sign in to see all peers for Charlie s Holdings Inc .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Charlie S Holdings Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Charlie s Holdings Inc | Q2 2026 | +110.5 % | - |
| Coca Cola Co | Q3 2026 | +2.8 % | -20.9 % |
| Pepsico Inc | Q3 2026 | +3.7 % | -7.7 % |
| Altria Group Inc | Q3 2026 | +166.9 % | +101.9 % |
| Monster Beverage Corp | Q2 2026 | +19.6 % | +54.2 % |
| Keurig Dr Pepper Inc | Q2 2026 | +122.4 % | +69.4 % |
Sign in to see all peers for Charlie s Holdings Inc .
Charlie S Holdings Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Charlie s Holdings Inc | - | - | - |
| Coca Cola Co | 13.85% | 14.46% | 39.81% |
| Pepsico Inc | 9.90% | 13.66% | 50.41% |
| Altria Group Inc | 23.62% | 26.82% | - |
| Monster Beverage Corp | 20.35% | 24.75% | 24.96% |
| Keurig Dr Pepper Inc | 2.21% | 2.34% | 5.47% |
Sign in to see all peers for Charlie s Holdings Inc .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Charlie S Holdings Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Charlie s Holdings Inc | - | 1.21 |
| Coca Cola Co | 28.11 | 8.05 |
| Pepsico Inc | 17.71 | 1.96 |
| Altria Group Inc | 15.55 | 6.04 |
| Monster Beverage Corp | 42.25 | 9.79 |
| Keurig Dr Pepper Inc | 37.19 | 2.50 |
| PEERS AVERAGE | 23.07 | 4.17 |
Sign in to see all peers for Charlie s Holdings Inc .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.